
CAS 313474-59-8
:Formule :C25H33BrO6
InChI :InChI=1S/C25H33BrO6/c1-4-5-21-31-20-11-17-16-7-6-14-10-15(28)8-9-22(14,2)24(16,26)18(29)12-23(17,3)25(20,32-21)19(30)13-27/h8-10,16-18,20-21,27,29H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22-,23-,24-,25+/m0/s1
Code InChI :KSJCBAYFDFDDEM-QRXHXLOESA-N
SMILES :CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@]4([C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)Br)C
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
8 produits trouvés.
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
Bromobudesonide
CAS :Heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C25H33BrO6Couleur et forme :White Off-White SolidMasse moléculaire :508.14605(6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-6b-bromo-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one (B
CAS :(6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-6b-bromo-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one (BFormule :C25H33BrO6Degré de pureté :98%Masse moléculaire :509.43Budesonide EP Impurity J (Mixture of Diastereomers)
CAS :Formule :C25H33BrO6Couleur et forme :White To Off-White SolidMasse moléculaire :509.44(6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-6b-Bromo-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one
CAS :Formule :C25H33BrO6Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :509.429916alpha,17-[(1RS)-Butylidenebis(oxy)]-9alpha-bromo-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
CAS :Formule :C25H33BrO6Couleur et forme :NeatMasse moléculaire :509.439Alpha-Bromobudesonide
CAS :Produit contrôléImpurity Budesonide EP Impurity J
Applications 9α-Bromobudesonide (Budesonide EP Impurity J) is an impurity of Budesonide (B689460), a non-halogenated glucocorticoid intended for the local treatment of lung disease.
References Ryrfeldt, Å., et al.: Eur. J. Respir. Dis., 122, 86 (1981); Vestbo, J., et al.: Lancet, 353, 1819 (1999)Formule :C25H33BrO6Couleur et forme :NeatMasse moléculaire :509.43








